Selenium and Diabetes: More Bad News for Supplements
Authors: Joachim Bleys, Ana Navas-Acien, Eliseo Guallar
Journal: Annals of Internal Medicine (2007)

Editorials21 August 2007Selenium and Diabetes: More Bad News for SupplementsFREEJoachim Bleys, MD, MPH, Ana Navas-Acien, MD, PhD, and Eliseo Guallar, MD, DrPHJoachim Bleys, MD, MPHFrom Welch Center for Prevention, Epidemiology and Clinical Research, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD 21205., Ana Navas-Acien, MD, PhDFrom Welch Center for Prevention, Epidemiology and Clinical Research, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD 21205., and Eliseo Guallar, MD, DrPHFrom Welch Center for Prevention, Epidemiology and Clinical Research, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD 21205.Author, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-147-4-200708210-00177 SectionsAboutVisual AbstractPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail In this issue, Stranges and colleagues (1) report findings from the NPC (Nutritional Prevention of Cancer) trial that show an increased risk for diabetes among participants randomly assigned to receive supplements with 200 μg of selenium daily for 7.7 years compared with placebo. This effect was largely limited to participants in the top tertile of plasma selenium levels at baseline (>121.6 ng/mL). In this group, the hazard ratio for incident diabetes in persons using selenium supplements compared with placebo was 2.70 (95% CI, 1.30 to 5.61). The NPC trial is the largest and longest available experimental study of selenium supplements compared with placebo. Although diabetes was not a primary end point of the trial and the investigators used self-report and medical records to assign the diagnosis, the results have credibility because of the randomized, double-blind design; the monitoring of baseline and follow-up plasma selenium levels; and other methodological strengths. The public health implications of these findings are substantial: More than 1% of the U.S. population take selenium supplements, and more than 35% take multivitamin and multimineral supplements (2) that often contain selenium.Before it was found to be an essential nutrient (3, 4), selenium was considered highly toxic to animals and humans (5). The key breakthrough occurred in 1973, when Rotruck and colleagues (3) discovered that selenium protected against oxidative damage by means of selenium-dependent glutathione peroxidase. Selenium is incorporated into selenoproteins as selenocysteine through a complex genetic mechanism encoded by the UGA codon (6). Selenoproteins, including glutathione peroxidases, thioredoxin reductases, iodothyronine deiodinases, and selenoprotein P, have important enzymatic functions. Through selenoproteins, selenium is involved in many biological functions, including protection against oxidative stress, immune function, and thyroid function (6, 7).The concentration and activity of glutathione peroxidases and other selenoproteins increase with increasing intake of selenium until the dose–response relationship reaches a plateau. With the possible exception of selenoprotein P, this plateau of maximum activity is reached at plasma selenium levels of 70 to 90 ng/mL. At greater levels, additional selenium intake further increases the plasma selenium level because of nonspecific incorporation of selenomethionine into albumin and other proteins rather than increased concentration or activity of glutathione peroxidases (8, 9). In the United States, dietary intake of selenium is relatively high (80 to 165 µg/d) (9). Indeed, 99% and 50% of adults have serum selenium levels greater than 95 ng/mL and 124 ng/mL (9), respectively. In short, the risk for selenium deficiency in the United States is negligible, and the use of selenium supplements in this country is unlikely to increase the antioxidant activity of glutathione peroxidases.Not only are the benefits of selenium supplementation in the United States uncertain, but selenium has a narrow therapeutic range and may be toxic (5, 9). Overt symptoms of acute and chronic selenium toxicity include brittleness and loss of hair and nails, fatigue, neurologic damage, hepatic degeneration, gastrointestinal disturbances, enlarged spleen, and chronic dermatitis (9).The Institute of Medicine set the Tolerable Upper Intake Level (UL) for selenium at 400 μg/d to avoid visible symptoms of selenium toxicity in sensitive persons (5, 9). In the NPC trial, participants in the active intervention group received daily supplementation with 200 μg of selenium in addition to their usual selenium intake (1). The increased risk for diabetes in this group alerts us that asymptomatic yet pathologic changes related to chronic selenium toxicity could take place at intake levels lower than the currently defined UL. If the findings of Stranges and colleagues are confirmed, the Institute of Medicine should revise the current upper UL.The apparent increase in risk for diabetes with selenium supplementation in persons with a dietary intake of selenium in the high-normal range may be biologically plausible. The potential diabetogenic effect of excess selenium could be explained paradoxically by the ability of some selenium compounds to generate reactive oxygen species (10). Selenium may also accumulate in the pancreatic tissue of several animals (5). Under conditions of oxidative stress, reactive oxygen species may increase insulin resistance and affect pancreatic β-cell function (11).Corroborative epidemiologic evidence is limited. In NHANES III (Third National Health and Nutrition Examination Survey), which was conducted in a representative sample of the U.S. population, participants in the highest quintile of serum selenium levels (≥137.7 ng/mL) had an increased prevalence of diabetes compared with those in the lowest quintile (<111.6 ng/mL) (12). An observational analysis within the SU.VI.MAX (Supplementation with Antioxidant Vitamins and Minerals) trial also found a positive association between baseline plasma selenium levels and fasting plasma glucose levels at baseline and after 7.5 years of follow-up (13). However, a substudy of the Health Professionals Follow-up Study found an inverse association between toenail selenium levels and the prevalence of diabetes at baseline (14), and a small cross-sectional study of Asian persons residing in Singapore found similar mean serum selenium levels among participants with and without diabetes (15).High-quality prospective cohort studies and randomized trials investigating the effects of dietary selenium and selenium supplements on the incidence of diabetes are needed. These studies should closely monitor diabetes incidence by measuring fasting plasma glucose and other indices of glucose metabolism in groups with a wide range of selenium intake. Ongoing trials (16, 17) could also be used to confirm the findings of Stranges and colleagues. These studies can help us to understand the dose–response relationship between selenium intake and health outcomes, the benefits and risks for selenium supplementation on diabetes and other chronic health outcomes, and the existence of vulnerable subgroups at risk for side effects. However, until further randomized, controlled trials show that selenium supplementation does not cause diabetes or establish that the potential risk for diabetes is outweighed by yet unproven health benefits, people with diets that provide the Recommended Dietary Allowance for selenium (55 µg/d) (9) should avoid selenium supplements, except in the context of experimental studies.Although obesity and lack of physical activity are the major factors responsible for the diabetes epidemic, environmental exposures may also be important. High selenium levels (12) or use of selenium supplements by persons with adequate selenium status (1) may contribute to this problem, although the extent of the role of these factors is unknown. Furthermore, the potential harmful effects of selenium supplementation in persons with high-normal selenium levels could extend beyond diabetes. A secondary analysis of the NPC trial identified some benefit of selenium supplementation for cancer prevention among participants with baseline plasma selenium levels less than 121.6 ng/mL but a possible small increase in total cancer risk among participants with higher levels (hazard ratio, 1.20 [CI, 0.77 to 1.86]) (18).In the past decade, randomized, controlled clinical trials have shown that β-carotene and vitamin E supplements, which were widely believed to be safe, increase mortality and morbidity (19, 20). No dietary supplement, including selenium, has proven useful so far for the prevention of cardiovascular disease or cancer in the general U.S. population. The balance of the potential benefits and harms of selenium supplementation depends on the dietary selenium intake in different countries. However, the U.S. public needs to know that most people in this country receive adequate selenium from their diet. By taking selenium supplements on top of an adequate dietary intake, people may increase their risk for diabetes.Joachim Bleys, MD, MPHAna Navas-Acien, MD, PhDEliseo Guallar, MD, DrPHWelch Center for Prevention, Epidemiology and Clinical Research, Johns Hopkins University Bloomberg School of Public HealthBaltimore, MD 21205References1. Stranges S, Marshall JR, Natarajan R, Donahue RP, Trevisan M, Cappuccio FP, et al. Effects of long-term selenium supplementation on the incidence of type 2 diabetes. A randomized trial. Ann Intern Med. 2007;147:217-23. LinkGoogle Scholar2. Radimer K, Bindewald B, Hughes J, Ervin B, Swanson C, Picciano MF. Dietary supplement use by US adults: data from the National Health and Nutrition Examination Survey, 1999-2000. Am J Epidemiol. 2004;160:339-49. [PMID: 15286019] CrossrefMedlineGoogle Scholar3. Rotruck JT, Pope AL, Ganther HE, Swanson AB, Hafeman DG, Hoekstra WG. Selenium: biochemical role as a component of glutathione peroxidase. Science. 1973;179:588-90. [PMID: 4686466] CrossrefMedlineGoogle Scholar4. Schwarz K, Calvin F. Selenium as an integral part of factor 3 against dietary necrotic liver degeneration. J Am Chem Soc. 1957;79:3292-3. CrossrefGoogle Scholar5. U.S. Department of Health and Human Services. Toxicological Profile for Selenium. Atlanta, GA: U.S. Department of Health and Human Services, Public Health Service; 2003. Google Scholar6. Papp LV, Lu J, Holmgren A, Khanna KK. From selenium to selenoproteins: synthesis, identity, and their role in human health. Antioxid Redox Signal. 2007;9:775-806. [PMID: 17508906] CrossrefMedlineGoogle Scholar7. Rayman MP. The importance of selenium to human health. Lancet. 2000;356:233-41. [PMID: 10963212] CrossrefMedlineGoogle Scholar8. Burk RF. Selenium, an antioxidant nutrient. Nutr Clin Care. 2002;5:75-9. [PMID: 12134713] CrossrefMedlineGoogle Scholar9. Dietary Reference Intakes for Vitamin C, Vitamin E, Selenium, and Carotenoids. A Report of the Panel on Dietary Antioxidants and Related Compounds, Subcommittees on Upper Reference Levels of Nutrients and Interpretation and Uses of Dietary Reference Intakes, and the Standing Committee on the Scientific Evaluation of Dietary Reference Intakes. Washington, DC: National Academy Pr; 2000. Google Scholar10. Drake EN. Cancer chemoprevention: selenium as a prooxidant, not an antioxidant. Med Hypotheses. 2006;67:318-22. [PMID: 16574336] CrossrefMedlineGoogle Scholar11. Fridlyand LE, Philipson LH. Oxidative reactive species in cell injury: mechanisms in diabetes mellitus and therapeutic approaches. Ann N Y Acad Sci. 2005;1066:136-51. [PMID: 16533924] CrossrefMedlineGoogle Scholar12. Bleys J, Navas-Acien A, Guallar E. Serum selenium and diabetes in U.S. adults. Diabetes Care. 2007;30:829-34. [PMID: 17392543] CrossrefMedlineGoogle Scholar13. Czernichow S, Couthouis A, Bertrais S, Vergnaud AC, Dauchet L, Galan P, et al. Antioxidant supplementation does not affect fasting plasma glucose in the Supplementation with Antioxidant Vitamins and Minerals (SU.VI.MAX) study in France: association with dietary intake and plasma concentrations. Am J Clin Nutr. 2006;84:395-9. [PMID: 16895889] MedlineGoogle Scholar14. Rajpathak S, Rimm E, Morris JS, Hu F. Toenail selenium and cardiovascular disease in men with diabetes. J Am Coll Nutr. 2005;24:250-6. [PMID: 16093402] CrossrefMedlineGoogle Scholar15. Hughes K, Choo M, Kuperan P, Ong CN, Aw TC. Cardiovascular risk factors in non–insulin-dependent diabetics compared to non-diabetic controls: a population-based survey among Asians in Singapore. Atherosclerosis. 1998;136:25-31. [PMID: 9544728] CrossrefMedlineGoogle Scholar16. Lippman SM, Goodman PJ, Klein EA, Parnes HL, Thompson IM, Kristal AR, et al. Designing the Selenium and Vitamin E Cancer Prevention Trial (SELECT). J Natl Cancer Inst. 2005;97:94-102. [PMID: 15657339] CrossrefMedlineGoogle Scholar17. Marshall JR, Sakr W, Wood D, Berry D, Tangen C, Parker F, et al. Design and progress of a trial of selenium to prevent prostate cancer among men with high-grade prostatic intraepithelial neoplasia. Cancer Epidemiol Biomarkers Prev. 2006;15:1479-84. [PMID: 16896036] CrossrefMedlineGoogle Scholar18. Duffield-Lillico AJ, Reid ME, Turnbull BW, Combs GF, Slate EH, Fischbach LA, et al. Baseline characteristics and the effect of selenium supplementation on cancer incidence in a randomized clinical trial: a summary report of the Nutritional Prevention of Cancer Trial. Cancer Epidemiol Biomarkers Prev. 2002;11:630-9. [PMID: 12101110] MedlineGoogle Scholar19. Miller ER, Pastor-Barriuso R, Dalal D, Riemersma RA, Appel LJ, Guallar E. Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality. Ann Intern Med. 2005;142:37-46. [PMID: 15537682] LinkGoogle Scholar20. Bjelakovic G, Nikolova D, Gluud LL, Simonetti RG, Gluud C. Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: systematic review and meta-analysis. JAMA. 2007;297:842-57. [PMID: 17327526] CrossrefMedlineGoogle Scholar Comments0 CommentsSign In to Submit A Comment Author, Article, and Disclosure InformationAffiliations: From Welch Center for Prevention, Epidemiology and Clinical Research, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD 21205.Disclosures: None disclosed.Corresponding Author: Eliseo Guallar, MD, DrPH, Department of Epidemiology, Welch Center for Prevention, Epidemiology and Clinical Research, Johns Hopkins University Bloomberg School of Public Health, 2024 East Monument Street, Room 2-639, Baltimore, MD 21205; e-mail, [email protected]edu.Current Author Addresses: Drs. Bleys and Guallar: Department of Epidemiology, Welch Center for Prevention, Epidemiology and Clinical Research, Johns Hopkins University Bloomberg School of Public Health, 2024 East Monument Street, Suite 2-600, Baltimore, MD 21205.Dr. Navas-Acien: Department of Environmental Health Sciences, Johns Hopkins University Bloomberg School of Public Health, 615 North Wolfe Street, Room W7033B, Baltimore, MD 21205. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetailsSee AlsoEffects of Long-Term Selenium Supplementation on the Incidence of Type 2 Diabetes Saverio Stranges , James R. Marshall , Raj Natarajan , Richard P. Donahue , Maurizio Trevisan , Gerald F. Combs , Francesco P. Cappuccio , Antonio Ceriello , and Mary E. Reid Metrics Cited byDesign, Synthesis and Antitumor Activity of Novel Selenium-Containing Tepotinib Derivatives as Dual Inhibitors of c-Met and TrxRThe association between dietary selenium intake and Hashimoto's thyroiditis among US adults: National Health and Nutrition Examination Survey (NHANES), 2007–2012Association of Urinary and Dietary Selenium and of Serum Selenium Species with Serum Alanine Aminotransferase in a Healthy Italian PopulationA systematic review and dose-response meta-analysis of exposure to environmental selenium and the risk of type 2 diabetes in nonexperimental studiesThe Fact and Fiction of Nutritional Claims About Health and LongevityRole of Minerals and Trace Elements in Diabetes and Insulin ResistanceSelenium and iodine in diabetes mellitus with a focus on the interplay and speciation of the elementsEnvironmental Selenium and Human Health: an UpdateCross-sectional Study: Relationship Between Serum Selenium and Hypertension in the Shandong Province of ChinaCardiometabolic response of juvenile rainbow trout exposed to dietary selenomethionineSelenium and Cardiovascular Disease: Epidemiological Evidence of a Possible U-Shaped RelationshipRelationship between serum selenium, sociodemographic variables, other trace elements and lipid profile in an adult Spanish populationSelenium Concentration in Korean Patients with Thyroid Disease: a Preliminary ReportSelenium and its inorganic compounds [MAK Value Documentation, 2011]Effects of selenium on endothelial dysfunction and metabolic profile in low dose streptozotocin induced diabetic rats fed a high fat dietHigh levels of plasma selenium are associated with metabolic syndrome and elevated fasting plasma glucose in a Chinese population: A case-control studySelenium and its CompoundsArsenic and selenium toxicity and their interactive effects in humansMushroom and dietary selenium intakes in relation to fasting glucose levels in a free-living Italian adult population: The Moli-sani ProjectEvaluation of serum metallothionein-1, selenium, zinc, and copper in Ghanaian type 2 diabetes mellitus patientsSelenium and hypertensionSelenium and Prostate Cancer Prevention: Insights from the Selenium and Vitamin E Cancer Prevention Trial (SELECT)Selenium Supranutrition: Are the Potential Benefits of Chemoprevention Outweighed by the Promotion of Diabetes and Insulin Resistance?Selenium and the thyroid gland: more good news for cliniciansHarmful Effects of AntioxidantsHarmful Effects of Antioxidant TherapyDesign and Baseline Characteristics of Participants in a Phase III Randomized Trial of Celecoxib and Selenium for Colorectal Adenoma PreventionInfluence of serum selenium concentrations on hypertensionGender differences in copper, zinc and selenium status in diabetic-free metabolic syndrome European population – The IMMIDIET studyAntioxidant supplements for prevention of mortality in healthy participants and patients with various diseasesSelen und seine anorganischen Verbindungen [MAK Value Documentation in German language, 2011]Harmful Effects of Antioxidant TherapyMedicinal Inorganic Chemistry: An IntroductionToxicology and pharmacology of selenium: emphasis on synthetic organoselenium compoundsFish oil, selenium and mercury in relation to incidence of hypertension: a 20-year follow-up studyBoth Maximal Expression of Selenoproteins and Selenoprotein Deficiency Can Promote Development of Type 2 Diabetes-Like Phenotype in MiceSelenium in Human Health and DiseaseImpacts of Dietary Selenium Deficiency on Metabolic Phenotypes of Diet-Restricted GPX1-Overexpressing MiceTwo Tales of Antioxidant Enzymes on β Cells and DiabetesGlutathione Peroxidase 1 and DiabetesMedicinal Inorganic Chemistry: An IntroductionAntioxidants, trace elements and metabolic syndrome in elderly subjectsSelenium status and cardiometabolic health: State of the evidenceA Nutrient Approach to Prostate Cancer Prevention: The Selenium and Vitamin E Cancer Prevention Trial (SELECT)Selenium Enigma: Health Implications of an Inadequate SupplyHierarchical regulation of selenoprotein expression and sex-specific effects of seleniumVitaminas e minerais com propriedades antioxidantes e risco cardiometabólico: controvérsias e perspectivasFoodstuffs for Preventing Cancer: The Preclinical and Clinical Development of BerriesÉléments-trace essentiels en nutrition humaine : chrome, sélénium, zinc et ferPositive and Negative Regulation of Insulin Signaling by Reactive Oxygen and Nitrogen SpeciesEffect of Sodium Selenite Supplementation on Glucose Intolerance and Pancreatic Oxidative Stress in Type 2 Diabetic Mice under Different Selenium StatusRisk of Chronic Low-Dose Selenium Overexposure in Humans: Insights From Epidemiology and BiochemistryThe Effect of Microelements Supplementation on β-oxidation Activity in Healthy and Type 1 Diabetic RatsHigh Potential for Selenium Biofortification of Lentils (Lens culinaris L.)Nutrition and the Older DiabeticSerum selenium and serum lipids in US adultsSerum Selenium Levels in Healthy Women in Tabriz, IranAntioxidant supplements for prevention of mortality in healthy participants and patients with various diseasesSelenium intake and cardiovascular risk: what is new?What Is the Latest Research on the Connection between Selenium and Diabetes? 21 August 2007Volume 147, Issue 4Page: 271-272KeywordsBlood plasmaCancer preventionClinical epidemiologyDietGlutathioneNutritionPeroxidasesPrevention, policy, and public healthSeleniumToxicity ePublished: 21 August 2007 Issue Published: 21 August 2007 Copyright & PermissionsCopyright © 2007 by American College of Physicians. All Rights Reserved.PDF downloadLoading ...